NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $63.4M
1-Year Est. Return 35.61%
This Quarter Est. Return
1 Year Est. Return
+35.61%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$63.4M
AUM Growth
-$59.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
35
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

1
+$9.4M
2
+$9.17M
3
+$6.61M
4
PTGX icon
Protagonist Therapeutics
PTGX
+$5.87M
5
SLNO icon
Soleno Therapeutics
SLNO
+$5.69M

Sector Composition

1 Healthcare 99.82%
2 Materials 0.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRMY icon
1
Harmony Biosciences
HRMY
$1.49B
$11.6M 18.37%
368,665
ILMN icon
2
Illumina
ILMN
$14.7B
$11.4M 17.93%
119,196
OCS icon
3
Oculis Holding
OCS
$1.14B
$9.99M 15.75%
514,702
INCY icon
4
Incyte
INCY
$17.1B
$4.02M 6.34%
59,022
ONC
5
BeOne Medicines Ltd
ONC
$34.8B
$3.81M 6%
15,722
MDGL icon
6
Madrigal Pharmaceuticals
MDGL
$9.78B
$3.59M 5.66%
11,872
RXRX icon
7
Recursion Pharmaceuticals
RXRX
$2.56B
$3.36M 5.3%
664,610
RYTM icon
8
Rhythm Pharmaceuticals
RYTM
$7.32B
$3.1M 4.89%
49,120
ASND icon
9
Ascendis Pharma
ASND
$12.7B
$2.35M 3.7%
13,600
LAB icon
10
Standard BioTools
LAB
$485M
$2.26M 3.56%
1,883,179
ACAD icon
11
Acadia Pharmaceuticals
ACAD
$3.52B
$2.22M 3.5%
102,984
ARGX icon
12
argenx
ARGX
$51.9B
$1.54M 2.43%
2,800
KYMR icon
13
Kymera Therapeutics
KYMR
$4.28B
$1.35M 2.12%
30,875
RVMD icon
14
Revolution Medicines
RVMD
$10.1B
$708K 1.12%
19,253
REPL icon
15
Replimune Group
REPL
$351M
$592K 0.93%
63,719
-350,527
BCYC
16
Bicycle Therapeutics
BCYC
$566M
$479K 0.76%
68,943
BOLT icon
17
Bolt Biotherapeutics
BOLT
$11M
$337K 0.53%
58,347
-1
TRDA icon
18
Entrada Therapeutics
TRDA
$223M
$330K 0.52%
49,082
RANI icon
19
Rani Therapeutics
RANI
$78.6M
$254K 0.4%
493,584
BSLK
20
Bolt Projects Holdings
BSLK
$10.8M
$114K 0.18%
40,597
-1
AFMD
21
DELISTED
Affimed
AFMD
– –
-37,247
ALXO icon
22
ALX Oncology
ALXO
$80.3M
– –
-41,950
DBVT
23
DBV Technologies
DBVT
$464M
– –
-37,095
GERN icon
24
Geron
GERN
$766M
– –
-1,373,550
KALV icon
25
KalVista Pharmaceuticals
KALV
$561M
– –
-154,522
1
2